Human recombinant growth hormone

DRUG3 trials

Sponsors

National Center for Research Resources (NCRR), Hamilton Health Sciences Corporation, University of Maryland, Baltimore

Conditions

Cystic FibrosisHeart FailureOsteoporosis Pseudoglioma Syndrome

Phase 2

Evaluation of the Effect of Human Recombinant Growth Hormone in Patients With Advanced Heart Failure

CompletedNCT00182169

Hamilton Health Sciences CorporationHeart Failure

Start: 1997-07-31End: 2005-06-30Target: 80Updated: 2005-09-16

Phase 3

Growth Hormone Use in Cystic Fibrosis - a Multicenter Study

CompletedNCT00005112

National Center for Research Resources (NCRR)Cystic Fibrosis

Updated: 2005-06-24

Unknown Phase

Growth Hormone for Osteoporosis Pseudoglioma Syndrome

WithdrawnNCT01614171

University of Maryland, BaltimoreOsteoporosis Pseudoglioma Syndrome

Start: 2013-12-31End: 2015-12-31Updated: 2022-04-08